The dynamics of the US nasal drug delivery market are increasingly influenced by changing patient preferences, highlighting a significant shift toward non-invasive treatment options. By 2035, the market is expected to reach a size of approximately 1,574.98 million USD, up from 1,003.8 million USD in 2024, reflecting a compound annual growth rate of 4.18%. This anticipated growth is largely...